Clinical Trials Using PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170
Clinical trials are research studies that involve people. The clinical trials on this list are studying PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Clinical Study of Oral PI3K / mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Clinical study of oral PI3K / mTOR inhibitor P7170 in patients with advanced refractory solid tumors. The primary objective is to determine the maximum tolerated dose and dose limiting toxicity of oral PI3K / mTOR inhibitor P7170 in patients with advanced refractory solid tumors
Location: See Clinical Trials.gov